Lin Yu-Hsininsider trades
In SEC Form 4 filings, Lin Yu-Hsin is listed as Chief Executive Officer of Belite Bio, Inc (BLTE). In the last 90 days, Lin Yu-Hsin sold $19.08M of Belite Bio, Inc (BLTE) on the open market and bought none. All 19 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BLTEBelite Bio, Inc | Chief Executive Officer | 19 | Sep 9 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-09
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BLTEBelite Bio, Inc | Sep 8 | Sep 9 | S | 2,400 | $194.33 | Sale −$466,399 | 93,734 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 8 | Sep 9 | S | 6,090 | $195.62 | Sale −$1,191,325 | 87,644 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 8 | Sep 9 | S | 6,058 | $196.54 | Sale −$1,190,642 | 81,586 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 8 | Sep 9 | S | 8,752 | $197.36 | Sale −$1,727,275 | 72,834 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 8 | Sep 9 | S | 2,700 | $198.09 | Sale −$534,845 | 70,134 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 2,635 | $180.29 | Sale −$475,071 | 167,934 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 2,587 | $181.24 | Sale −$468,877 | 165,347 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 3,413 | $182.50 | Sale −$622,869 | 161,934 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 4,955 | $183.30 | Sale −$908,228 | 156,979 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 6,252 | $184.52 | Sale −$1,153,647 | 150,727 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 4,593 | $185.34 | Sale −$851,286 | 146,134 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 7,800 | $186.32 | Sale −$1,453,323 | 138,334 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 6,200 | $187.25 | Sale −$1,160,964 | 132,134 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 3,045 | $188.26 | Sale −$573,253 | 129,089 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 8,955 | $189.34 | Sale −$1,695,552 | 120,134 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 600 | $190.39 | Sale −$114,232 | 119,534 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 11,080 | $191.15 | Sale −$2,117,909 | 108,454 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 4,209 | $192.54 | Sale −$810,412 | 104,245 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Sep 4 | Sep 9 | S | 8,111 | $193.13 | Sale −$1,566,439 | 96,134 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.